Romidepsin is a histone deacetylase (HDAC) inhibitor exhibiting anti-tumor activity. It targets HDAC1, HDAC2, HDAC4, and HDAC6. This compound is utilized in PROTAC development for its ability to inhibit HDACs and facilitate targeted protein degradation. Reagent-grade; for laboratory research purposes only.
Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye